跳至主要内容
临床试验/CTRI/2026/01/100406
CTRI/2026/01/100406招募中2 期

Effect of Bempedoic acid on arterial Stiffness in patients with Diabetic dyslipidemia: a Pilot Randomized controlled trial

ARINDAM NASKAR1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2026年1月16日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
48
试验地点
1

研究概览

简要总结

A preclinical study has demonstrated Bempedoic acid may have favourable effect on arterial stiffness in male Sprague-Dawley Rats. However there is lack of human trial in existing literature to demonstrate effect of Bempedoic acid on vascular stiffness. Our study aims to frill this knowledge gap  whether Bempedoic acid can actually reduce arterial stiffness that may add new insight to existing literature

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
40.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • Established diagnosis of type 2 diabetes mellitus (T2DM) [As per American Diabetes Association criteria for diagnosis of T2DM] Serum LDL more than 70 mg/dl with Atorvastatin (20mg daily) therapy for at least 6 months Willing to providing written informed consent.

排除标准

  • Patients having estimated GFR less than 30 ml/min/1.73m2 by CKD-EPI criteria Patients known Heart failure (Stage III or IV) Severe liver dysfunction (Child Pugh C) Baseline AST and ALT more than 3 times of upper limit Hemoglobin less than 8 gm/dl Tobacco abusers and any kind of substance abusers Patients with malignancy and/or on chemotherapy Patients with infectious disease like HIV Hepatitis B and Hepatitis C Hyperuricemia (Male more than 7 mg/dl, female more than 6 mg/dl) History of Tendon rupture.

研究者

发起方
ARINDAM NASKAR
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Arindam Naskar

School of Tropical Medicine

研究点 (1)

Loading locations...

相似试验

Whether Bempedoic acid has any effect on hardening... | 临床试验